Detection of plasmid-mediated quinolone resistance determinants and the emergence of multidrug resistance in clinical isolates of Shigella in SiXian area, China

Diagnostic Microbiology and Infectious Disease

Volumn 75, Issue 3, 2013, Pages 327-329

  Zhu, Yu lin ^a   Yang, Hai Fei ^a   Liu, Yan yan ^a   Hu, Li fen ^a   Cheng, Jun ^a   Ye, Ying ^a,b   Li, Jia bin ^a,b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Anhui Center for Surveillance of Bacterial Resistance   (China)

Author keywords

Multidrug resistance; PMQR; QRDR; Shigella

Indexed keywords

AMIKACIN; AMPICILLIN; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; MOXIFLOXACIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RNA METHYLTRANSFERASE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHINA; GENE MUTATION; INTEGRON; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID MEDIATED QUINOLONE RESISTANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SHIGELLA;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CHINA; CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSENTERY, BACILLARY; GENES, BACTERIAL; GENES, RRNA; HUMANS; INTEGRONS; MUTATION; PLASMIDS; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; SHIGELLA;

EID: 84873604770     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.12.001     Document Type: Article

References (17)

1. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 21th information supplement (M100-S21) 2011, CLSI, Wayne, PA.
2. Cavaco L.M., Hasman H., Xia S., Aarestrup F.M. QnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother 2009, 53:603-608.
3. Dallenne C., Da Costa A., Decré D., Favier C., Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J Antimicrob Chemother 2010, 65:490-495.
4. Doi Y., Arakawa Y. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 2007, 45:88-94.
5. Dutta S., Kawamura Y., Ezaki T. Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant Shigella dysenteriae serotype I clinical isolates from Kolkata, India. Antimicrob Agents Chemother 2005, 49:1660-1661.
6. Hu L.F., Chang X., Ye Y., Wang Z.X., Shao Y.B., Shi W., et al. Stenotrophomonas maltophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron. Int J Antimicrob Agents 2011, 37:230-234.
7. Luo Y.P., Yang J.Y., Zhang Y.J., Ye L.Y., Wang L.L., Guo L. Prevalence of β-lactamases and 16S rRNA methylase genes amongst clinical Klebsiella pneumoniae isolates carrying plasmid-mediated quinolone resistance determinants. Int J Antimicrob Agents 2011, 37:352-355.
8. Martínez-Martínez L., Alvaro Pascual A., Jacoby G.A. Quinolone resistance from a transferable plasmid. Lancet 1998, 351:797-799.
9. Poirel L., Cattoir V., Nordmann P. Plasmid-mediated quinolone resistance; interactions between human, animal, and environmental ecologies. Front Microbiol 2012, 3:1-7.
10. Robicsek A., Strahilevitz J., Sahm D.F., Jacoby G.A., Hooper D.C. qnr Prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 2006, 50:2872-2874.
11. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 2003, 51:1109-1117.
12. Veldman K., Cavaco L.M., Mevius D., Battisti A., Franco A., Botteldoorn N., et al. International collaborative study on the occurrence of plasmid-mediated quinolone resistance in Salmonella enteric and Escherichia coli isolated from animals, humans, food and the environment in 13 European countries. J Antimicrob Chemother 2011, 66:1278-1286.
13. Wu J.J., Ko W.C., Tsai S.H., Yan J.J. Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob Agents Chemother 2007, 51:1223-1227.
14. Wang M., Guo Q., Xu X., Wang X., Ye X., Wu S. New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis. Antimicrob Agents Chemother 2009, 53:1892-1897.
15. Wang M., Tran J.H., Jacoby G.A., Zhang Y., Wang F., Hooper D.C. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 2003, 47:2242-2248.
16. Xiong Z., Li J., Li T., Shen J., Hu F., Wang M. Prevalence of plasmid-mediated quinolone-resistance determinants in Shigella flexneri isolates from Anhui Province, China. J Antibiot (Tokyo) 2010, 63:187-189.
17. Yamane K., Wachino J., Suzuki S. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother 2007, 51:3354-3360.